WallStSmart

MKS Instruments Inc (MKSI)vsMesa Laboratories Inc (MLAB)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MKS Instruments Inc generates 1488% more annual revenue ($3.93B vs $247.54M). MKSI leads profitability with a 7.5% profit margin vs 1.5%. MKSI trades at a lower P/E of 55.9x. MKSI earns a higher WallStSmart Score of 55/100 (C-).

MKSI

Buy

55

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 4.7Quality: 7.0
Piotroski: 5/9Altman Z: 1.20

MLAB

Hold

38

out of 100

Grade: F

Growth: 4.0Profit: 4.5Value: 3.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MKSISignificantly Overvalued (-64.0%)

Margin of Safety

-64.0%

Fair Value

$158.01

Current Price

$243.68

$85.67 premium

UndervaluedFair: $158.01Overvalued
MLABSignificantly Overvalued (-1964.0%)

Margin of Safety

-1964.0%

Fair Value

$4.42

Current Price

$83.60

$79.18 premium

UndervaluedFair: $4.42Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MKSI0 strengths · Avg: 0/10

No standout strengths identified

MLAB1 strengths · Avg: 8.0/10
Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Areas to Watch

MKSI4 concerns · Avg: 2.5/10
Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Debt/EquityHealth
1.763/10

Elevated debt levels

P/E RatioValuation
55.9x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

MLAB4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
3.6%4/10

3.6% revenue growth

Market CapQuality
$455.25M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
2.2%3/10

ROE of 2.2% — below average capital efficiency

Profit MarginProfitability
1.5%3/10

1.5% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MKSI

Revenue growth of 10.6% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.

Bull Case : MLAB

The strongest argument for MLAB centers on Price/Book.

Bear Case : MKSI

The primary concerns for MKSI are Profit Margin, Debt/Equity, P/E Ratio. A P/E of 55.9x leaves little room for execution misses. Debt-to-equity of 1.76 is elevated, increasing financial risk.

Bear Case : MLAB

The primary concerns for MLAB are Revenue Growth, Market Cap, Return on Equity. A P/E of 126.8x leaves little room for execution misses. Thin 1.5% margins leave little buffer for downturns.

Key Dynamics to Monitor

MKSI carries more volatility with a beta of 1.92 — expect wider price swings.

MKSI is growing revenue faster at 10.6% — sustainability is the question.

MKSI generates stronger free cash flow (91M), providing more financial flexibility.

Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MKSI scores higher overall (55/100 vs 38/100) and 10.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MKS Instruments Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.

Visit Website →

Mesa Laboratories Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company is headquartered in Lakewood, Colorado.

Want to dig deeper into these stocks?